|Day Low/High||0.00 / 0.00|
|52 Wk Low/High||24.54 / 37.92|
MARLBOROUGH, Mass., Sept.
Analyst downgrades and mind-boggling P/E ratios do not matter in this current market.
The Healthcare sector has seen a revitalization year-to-date, and these investors may have wanted to participate in a continued move higher, risking a fraction of the price of a share in the event they were 'late to the party.'
Acquisition expands portfolio of men's health in-office procedures with adjunctive therapy for prostate cancer patients
MARLBOROUGH, Mass., Sept.
MARLBOROUGH, Mass., Aug.
Follow the experts. These biotech stocks have Wall Street's best analysts getting bullish.
It is all about perception, and here are strong names to pick up on market weakness.
Acquisition to Bolster Company's Venous Therapies Portfolio within Peripheral Interventions Division
CMS Grants NTAP Designation for The Sentinel® Cerebral Protection System
MARLBOROUGH, Mass., July 30, 2018 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 38 th Annual Canaccord Genuity Growth Conference on Wednesday, August 8, 2018 in Boston.
MARLBOROUGH, Mass., July 25, 2018 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated sales of $2.
MARLBOROUGH, Mass., July 24, 2018 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) has been notified of an unsolicited "mini-tender" offer by TRC Capital Corporation (TRC) to purchase up to three million shares of Boston Scientific's common...
Addition of FDA-cleared Sentinel® Cerebral Embolic Protection System to Expand Company's Structural Heart Offerings
Company to expand atrial fibrillation ablation therapy offerings with innovative cryoballoon platform
MARLBOROUGH, Mass., July 2, 2018 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the second quarter ended June 30, 2018 on Wednesday, July 25, 2018 at 8:00...
The heart-implant manufacturer is down some 4% over two days, but is up 128% year to date.
Jim Cramer takes a closer look at Magellan Midstream Partners, Xylem, Boston Scientific, Karyopharm Thereapeutics, Iovance Biotherapeutics, Casella Waste Systems and more.
Jim Cramer says higher rates always trigger rotations. Here's what investors should expect.
Jim Cramer and our other experts discuss the AT&T/Time Warner ruling, Alzheimer plays, and day traders risk.
The medical device firm issues an 8-K filing on the heels of a media report earlier this week that said it recently made a takeover approach to Boston Scientific.
Stocks closed higher on Monday as Wall Street prepares for an extraordinary week for risk events around the world.
Jim Cramer and our other experts discuss Trump and stocks, trade, and pajama trading.
The Wall Street Journal reports Stryker made a takeover approach for the medical device company.
MARLBOROUGH, Mass., June 1, 2018 /PRNewswire/ -- Boston Scientific (NYSE: BSX) today announced key data that will be presented at Digestive Disease Week (DDW) being held in Washington D.
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AMCX, APAM, BEAT, BSX, CIO, CRZO, EFII, FNB, LNDC, NTWK, OXSQ, SIR, VOC, WHG Downgrades: ABEV, ARNC, BMS, EMCI, ERII, ESGR, ESLT, GASS, IVZ, LPL, PICO Initiations: None Read on to get TheStreet Quant Ratings' detailed report:
When chartists look for the next market leaders they often go to stocks that have held up the best during corrections.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.